Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Motif Bio Appoints Clinical Development VP | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Motif Bio Appoints Clinical Development VP

Stephanie Noviello, MD, MPH joins the company from Bristol Myers Squibb

By: Betsy Louda

, Contract Pharma

Motif Bio announced that Stephanie Noviello, MD, MPH has joined the Company as vice president, Clinical Development.  She will report to David Huang, MD, PhD, chief medical officer, and will be a key contributor to the European Marketing Authorisation Application submission for iclaprim.


Dr. Noviello joins Motif Bio from Bristol-Myers Squibb, where she most recently was clinical program lead, Virology.  In this position, she served as clinical lead for the hepatitis B and C and HIV portfolios.  

David Huang, MD, PhD, chief medical officer of Motif Bio, said, “We are delighted to have Stephanie join Motif.  Her strategic insights, experience and leadership in late-stage global clinical trials and the regulatory process, including post-marketing requirements, make her ideally suited for this position. I am very excited and am looking forward to working with Stephanie as we continue to progress iclaprim towards an approval.”

 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics